URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Sandra McDonald

Concepts (176)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Biological Specimen Banks
2
2011
6
1.710
Why?
Carcinoma, Non-Small-Cell Lung
5
1993
70
0.910
Why?
Genomics
1
2012
49
0.840
Why?
Individualized Medicine
1
2011
5
0.830
Why?
Lung Neoplasms
7
1987
435
0.710
Why?
Lung
6
1989
1148
0.500
Why?
Head and Neck Neoplasms
4
1987
84
0.480
Why?
Interferon-beta
2
1993
63
0.440
Why?
Radiotherapy
2
1988
198
0.270
Why?
Radiotherapy Dosage
5
1987
202
0.260
Why?
Amifostine
1
1994
28
0.250
Why?
Salivary Glands
1
1994
66
0.240
Why?
Radiation Injuries
2
1988
131
0.240
Why?
Aryl Hydrocarbon Hydroxylases
1
2013
24
0.230
Why?
Genetic Research
1
2012
1
0.220
Why?
Humans
19
1987
37165
0.220
Why?
Aromatase Inhibitors
1
2012
3
0.220
Why?
Aromatase
1
2012
4
0.220
Why?
Pulmonary Fibrosis
2
1989
139
0.220
Why?
Alleles
1
2013
206
0.220
Why?
Ethics Committees, Research
1
2012
17
0.220
Why?
Genome, Human
1
2012
31
0.210
Why?
Information Dissemination
1
2012
24
0.210
Why?
RNA Splicing
1
2013
142
0.200
Why?
Informed Consent
1
2011
86
0.200
Why?
Quality Assurance, Health Care
1
2012
130
0.190
Why?
Pneumonia
2
1989
192
0.190
Why?
Carcinoma, Squamous Cell
2
1987
238
0.190
Why?
Physician's Role
1
2011
142
0.190
Why?
Drug Resistance, Neoplasm
1
2010
56
0.180
Why?
Laryngeal Neoplasms
1
1989
19
0.180
Why?
Insulin-Like Growth Factor I
1
2010
106
0.180
Why?
Neoplasms, Multiple Primary
1
1989
43
0.180
Why?
Cisplatin
2
1987
93
0.170
Why?
Smoking
1
2012
423
0.160
Why?
Neoplasm Metastasis
1
1987
229
0.140
Why?
Combined Modality Therapy
3
1987
491
0.140
Why?
Antibodies, Monoclonal
1
2010
748
0.140
Why?
Breast Neoplasms
1
2012
666
0.130
Why?
Radiation Pneumonitis
2
1995
43
0.130
Why?
Cystadenocarcinoma, Serous
1
2004
6
0.130
Why?
Cystadenocarcinoma, Papillary
1
2004
10
0.130
Why?
Adenocarcinoma, Clear Cell
1
2004
10
0.130
Why?
Dose-Response Relationship, Radiation
3
1989
216
0.130
Why?
Endometrial Neoplasms
1
2004
38
0.120
Why?
Brachytherapy
1
2004
109
0.120
Why?
Prognosis
4
1987
1078
0.110
Why?
Female
12
1987
20222
0.110
Why?
Exons
2
2012
170
0.110
Why?
Radiation Tolerance
2
1989
89
0.100
Why?
Survival Rate
2
1993
619
0.100
Why?
Neoplasms
1
1987
743
0.090
Why?
Recombinant Proteins
2
1993
770
0.090
Why?
Pilot Projects
2
1987
446
0.090
Why?
Pulmonary Surfactants
2
1989
250
0.090
Why?
Male
8
1988
20139
0.080
Why?
Middle Aged
6
1987
10013
0.080
Why?
Aged, 80 and over
3
1989
2588
0.070
Why?
Feasibility Studies
2
1992
212
0.070
Why?
Radiation Dosage
2
1993
122
0.070
Why?
Aged
5
1989
7392
0.070
Why?
Retrospective Studies
4
1994
2302
0.070
Why?
Antineoplastic Agents
2
2010
628
0.070
Why?
Respiratory Function Tests
1
1995
129
0.060
Why?
Clinical Protocols
1
1995
107
0.060
Why?
Fatigue
1
1996
124
0.060
Why?
Sodium Pertechnetate Tc 99m
1
1994
10
0.060
Why?
Secretory Rate
1
1994
43
0.060
Why?
Adult
5
1987
11572
0.060
Why?
Bronchoalveolar Lavage Fluid
2
1989
301
0.060
Why?
Radiation Protection
1
1994
23
0.060
Why?
DNA, Neoplasm
1
1994
129
0.060
Why?
Time Factors
2
1987
3234
0.060
Why?
Parotid Gland
1
1994
85
0.060
Why?
Antigens, Neoplasm
1
1994
109
0.060
Why?
Procollagen
1
1993
11
0.060
Why?
Cesium Radioisotopes
1
1993
29
0.060
Why?
Follow-Up Studies
2
1987
1889
0.060
Why?
Real-Time Polymerase Chain Reaction
1
2013
25
0.060
Why?
INDEL Mutation
1
2012
1
0.060
Why?
Radiation-Protective Agents
1
1993
41
0.060
Why?
High-Throughput Nucleotide Sequencing
1
2012
6
0.060
Why?
Exome
1
2012
2
0.050
Why?
Genome-Wide Association Study
1
2012
23
0.050
Why?
Radiation-Sensitizing Agents
1
1993
74
0.050
Why?
MAP Kinase Kinase Kinase 1
1
2012
9
0.050
Why?
MAP Kinase Kinase 4
1
2012
27
0.050
Why?
Molecular Targeted Therapy
1
2012
20
0.050
Why?
Nitriles
1
2012
39
0.050
Why?
Mice, Inbred Strains
1
1993
247
0.050
Why?
Respiration
1
1993
181
0.050
Why?
Androstadienes
1
2012
43
0.050
Why?
Microcomputers
1
1992
10
0.050
Why?
Evaluation Studies as Topic
2
1987
247
0.050
Why?
Radiotherapy, Computer-Assisted
1
1992
15
0.050
Why?
Mice
3
1993
6206
0.050
Why?
Chromosome Aberrations
1
2012
117
0.050
Why?
Triazoles
1
2012
40
0.050
Why?
Animals
5
1989
16416
0.050
Why?
Phospholipids
1
1993
192
0.050
Why?
Antineoplastic Combined Chemotherapy Protocols
1
1996
436
0.050
Why?
Genetic Variation
1
2012
147
0.050
Why?
DNA Primers
1
2013
422
0.050
Why?
Point Mutation
1
2012
178
0.050
Why?
Medical Oncology
1
1992
49
0.050
Why?
Cytokines
1
1995
575
0.050
Why?
Receptors, Estrogen
1
2012
180
0.050
Why?
Clinical Trials, Phase II as Topic
1
2010
14
0.050
Why?
Sensitivity and Specificity
1
1994
914
0.050
Why?
DNA Repair
1
2012
173
0.050
Why?
Clinical Trials as Topic
1
1994
685
0.050
Why?
Severity of Illness Index
1
1995
943
0.050
Why?
NIH 3T3 Cells
1
2010
27
0.050
Why?
Molecular Diagnostic Techniques
1
2010
8
0.050
Why?
Tissue Array Analysis
1
2010
36
0.050
Why?
Immunoglobulins, Intravenous
1
2010
37
0.050
Why?
Nuclear Proteins
1
1994
335
0.050
Why?
Hormone Antagonists
1
2010
45
0.050
Why?
Gene Expression Profiling
1
2012
304
0.050
Why?
Pulmonary Surfactant-Associated Proteins
1
1989
27
0.050
Why?
Apoproteins
1
1989
25
0.040
Why?
Radiation Injuries, Experimental
1
1989
89
0.040
Why?
Whole-Body Irradiation
1
1989
87
0.040
Why?
Base Sequence
1
2013
1721
0.040
Why?
Liver
1
2013
884
0.040
Why?
Treatment Outcome
2
1996
2671
0.040
Why?
Radioisotope Teletherapy
1
1987
4
0.040
Why?
Cobalt Radioisotopes
1
1987
17
0.040
Why?
Thoracic Neoplasms
1
1987
20
0.040
Why?
Colorectal Neoplasms
1
1989
143
0.040
Why?
Internship and Residency
1
1992
342
0.040
Why?
Infusions, Intravenous
1
1987
143
0.040
Why?
Lymphatic Metastasis
1
1987
153
0.040
Why?
Mutation
1
2012
1226
0.030
Why?
Palliative Care
1
1987
161
0.030
Why?
Brain Neoplasms
1
1988
282
0.030
Why?
Iridium Radioisotopes
1
2004
14
0.030
Why?
Radiopharmaceuticals
1
2004
49
0.030
Why?
Disease-Free Survival
1
2004
204
0.030
Why?
Tomography, X-Ray Computed
1
1988
785
0.030
Why?
Prostatic Neoplasms
1
1989
540
0.030
Why?
Neoplasm Staging
1
2004
354
0.030
Why?
Magnetic Resonance Imaging
1
1988
1019
0.030
Why?
United States
1
1989
2847
0.020
Why?
Brain
1
1988
1228
0.020
Why?
Adolescent
1
1987
5044
0.020
Why?
Etoposide
1
1996
83
0.020
Why?
Antineoplastic Agents, Phytogenic
1
1996
37
0.020
Why?
Radiotherapy, Adjuvant
1
1996
74
0.020
Why?
Chemotherapy, Adjuvant
1
1996
88
0.020
Why?
Treatment Failure
1
1996
131
0.020
Why?
Administration, Oral
1
1996
314
0.020
Why?
Drug Administration Schedule
1
1996
374
0.020
Why?
Platelet-Derived Growth Factor
1
1995
114
0.020
Why?
Ploidies
1
1994
18
0.020
Why?
Autoantigens
1
1994
34
0.020
Why?
Proliferating Cell Nuclear Antigen
1
1994
46
0.020
Why?
Interleukin-1
1
1995
221
0.020
Why?
Fibronectins
1
1995
151
0.020
Why?
Fluorescent Antibody Technique
1
1994
307
0.010
Why?
Collagen
1
1995
301
0.010
Why?
Survival Analysis
1
1996
589
0.010
Why?
Disease Progression
1
1996
533
0.010
Why?
Biopsy
1
1994
384
0.010
Why?
Transforming Growth Factor beta
1
1995
411
0.010
Why?
Computer Graphics
1
1992
18
0.010
Why?
Predictive Value of Tests
1
1994
609
0.010
Why?
Computer-Assisted Instruction
1
1992
20
0.010
Why?
Analysis of Variance
1
1994
749
0.010
Why?
Flow Cytometry
1
1994
603
0.010
Why?
Depression
1
1996
442
0.010
Why?
Mice, Inbred C57BL
1
1995
1700
0.010
Why?
Astrocytoma
1
1988
30
0.010
Why?
Glioblastoma
1
1988
63
0.010
Why?
Rabbits
1
1989
720
0.010
Why?
Biological Markers
1
1989
564
0.010
Why?

Visualizations


McDonald's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department